Screener
10x Genomics, Inc. TXG Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from 10x Genomics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s free cash flow margin?
- 10x Genomics, Inc. (TXG) reported free cash flow margin of 19.7% in Q2 2026.
- How has 10x Genomics, Inc.'s free cash flow margin changed year-over-year?
- 10x Genomics, Inc.'s free cash flow margin increased by 123.0% year-over-year, from 8.8% to 19.7%.
- What is the long-term trend for 10x Genomics, Inc.'s free cash flow margin?
- Over 3 years (2020 to 2025), 10x Genomics, Inc.'s free cash flow margin has grown at a -38.1% compound annual growth rate (CAGR), from -85.2% to 20.2%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about 10x Genomics, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude